The latest proposed bone regenerative therapy is a paint-like substance that coats implants or other devices to promote bone regrowth. It’s designed for use in treating combat injuries and lower back pain, among other issues. After about $9 million in grants from the Departments of Defense and Veterans Affairs, the substance, called AMP2, made by the company Theradaptive, is moving onto the next trial phase, a step ahead of testing on humans. Creator Luis Alvarez, a retired Army lieutenant colonel who served a year in Iraq, said coating an implant is much better than the current, more dangerous therapy for bone regrowth. Read more on Military.com.
'Paint' that Purports to Regrow Wounded Troops' Bones Moving Toward FDA Testing
